Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Appendices A-D Posted as supplied by authors
|
Search step |
Explanation |
|
Patient inclusion criteria |
|
|
Exploded MESH heading ‘Hypertension’ |
| |
Words in title: ‘hypertension’ or truncated ‘hypertensiv’ |
| |
Words in abstract at least twice: ‘hypertension’ or truncated ‘hypertensiv’ |
| |
1 OR 2 OR 3 |
|
intervention Inclusion criteria |
|
| |
Exploded MESH heading ‘Blood Pressure Monitoring, Ambulatory’ or ‘Blood Pressure Monitors’ or ‘Blood Pressure Determination’ |
| |
‘blood pressure’ within five words of truncated ‘measur’ or truncated ‘monitor’ in title or abstract |
| |
4 OR 5 OR 6 |
| |
‘home’ or truncated ‘self’ in title or abstract |
| |
Exploded MESH heading ‘Telemedicine’ |
| |
truncated ‘telemedic’ or truncated ‘telemonitor’ in title or abstract |
| |
8 OR 9 OR 10 |
| |
Blood pressure measurement AND home monitoring |
|
13. 4 and 12 |
Blood pressure measurement AND home monitoring AND Hypertension |
|
study desigN Inclusion criteria |
|
|
14. (random$ or placebo$) |
truncated ‘random’ or truncated ‘placebo in title or abstract or subject heading or publication type |
|
15. ((double$ or single$ or triple$ or treble$) and (blind$ or mask$)) |
(truncated ‘double’ or truncated ‘single’ or truncated ‘triple’ or truncated ‘treble’) in combination with (truncated ‘blind’ or truncated ‘mask’) |
|
16. (clinical trial or controlled clinical trial).pt |
publication type clinical trial or controlled clinical trial |
|
17. exp randomized controlled trials/ or randomized controlled trials.tw,sh. (27378) |
Exploded MeSH heading Randomized Controlled Trials or randomized controlled trials as a textword or subject heading |
|
18. Randomized controlled trial.pt |
publication type randomised controlled trial |
|
19. or/25-29 RCTs |
14 or 15 or 16 or 17 or 18 |
|
COMBINING patient group, intervention and STUDY DESIGN |
|
|
20. 13 and 29 |
Blood pressure measurement AND home monitoring AND Hypertension AND RCTs |
Appendix B: Methods of assessment of outcome
|
Date |
First author |
Blind outcome assessment |
Who took outcome blood pressure |
Automatic machine |
Method of taking outcome blood pressure |
|
1975 |
Carnahan |
Yes |
clinic nurses |
not stated |
Not stated |
|
1976 |
Haynes |
Yes |
researcher |
not stated |
"standardised method" |
|
1978 |
Johnson |
Yes |
researcher |
not stated |
Average of 2nd and 3rd readings 5 minutes apart |
|
1982 |
Earp |
not stated |
clinic staff |
not stated |
‘Average' blood pressure at 'routine clinic visit' |
|
1984 |
Pierce |
Yes |
clinic staff |
not stated |
medical records |
|
1984 |
Stahl |
No |
clinic nurse |
No |
Average of previous 6 months readings |
|
1988 |
Binstock |
not stated |
clinic nurse |
not stated |
Not stated |
|
1991 |
Midanik |
not stated |
researcher |
not stated |
Not stated |
|
1992 |
Soghikian |
No |
researcher |
No |
Second of two resting measurements, 1 minute apart |
|
1993 |
Muhlhauser |
not stated |
clinic staff |
not stated |
Mean of last two BPs in medical records |
|
1996 |
Friedman |
Yes |
researcher |
not stated |
Average of 2 readings 5 minutes apart |
|
1997 |
Zarnke |
Yes |
researcher |
Yes |
24 hr ambulatory BP |
|
1999 |
Bailey |
not stated |
research nurse |
not stated |
Sitting |
|
2000 |
Mehos |
Not stated |
researcher |
No |
Average of 2 readings |
|
2000 |
Vetter |
Not stated |
clinic physician |
No |
BP measured in morning before medication, after 5 mins rest. Mean of three sitting measurements. |
|
2001 |
Artinian |
Yes |
researcher |
Yes |
After 5 mins rest, mean of 2 readings |
|
2001 |
Broege |
not stated |
researcher |
Yes |
Average daytime ambulatory BP |
|
2001 |
Rogers |
Yes |
research nurse |
Yes |
24 hr ambulatory BP |
Appendix C. Blood pressure above target at follow-up
|
author |
Number of patients |
Percentage above target |
Relative risk |
Definition |
||
|
I |
C |
I |
C |
(95% CI) |
||
|
Haynes,1976 |
20 |
18 |
70 |
89 |
0.79 (0.57 to 1.10) |
dbp>=90 |
|
Earp,1982 (1 year) |
74 |
41 |
39 |
34 |
1.15 ( 0.69 to 1.91) |
dbp>=95 |
|
Earp,1982 (2 year) |
55 |
34 |
25 |
21 |
1.24 ( 0.56 to 2.75) |
dbp>=95 |
|
Stahl,1984 (1 year) |
125 |
149 |
29 |
36 |
0.79 ( 0.56 to 1.13) |
not defined |
|
Stahl,1984 (2 year) |
108 |
116 |
33 |
28 |
1.17 ( 0.79 to 1.74 |
not defined |
|
Mulhauser,1993 |
86 |
74 |
85 |
86 |
0.98 (0.86 to 1.11) |
dbp>90 or sbp>140 |
|
Mehos,2000 |
18 |
18 |
56 |
78 |
0.71 ( 0.44 to 1.16) |
dbp>90 or sbp>140 |
|
Vetter,2000 |
296 |
326 |
34 |
40 |
0.84 (0.68 to 1.03) |
dbp>90 |
Appendix D1. Systolic blood pressure. Mean and standard deviation of baseline, follow up and fall from baseline for intervention and control groups.
|
Author |
Number of subjects |
Baseline sbp |
Follow up sbp |
Fall from baseline |
Intervention effect |
||||
|
I |
C |
I |
C |
I |
C |
I |
C |
(95% CI) |
|
|
Carnaham,1975 |
49 |
48 |
153 |
157 |
135 |
146 |
18.0 (16.5)b |
10.5 (16.5) b |
7.5 (0.9 to 14.1) |
|
Haynes,1976 |
20 |
18 |
NR |
NR |
NR |
NR |
NC |
NC |
|
|
Johnson,1978 |
69 |
67 |
NR |
NR |
NR |
NR |
NC |
NC |
|
|
Earp,1982 |
74 |
41 |
NR |
NR |
NR |
NR |
NC |
NC |
|
|
Earp,1982 |
55 |
34 |
NR |
NR |
NR |
NR |
NC |
NC |
|
|
Pierce,1984 |
55 |
58 |
183 (23) |
180 (24) |
NR |
NR |
32.1 (22.3) |
33.3 (20.1) |
-1.2 (-9.0 to 6.6) |
|
Stah,1984 (1 year followup) |
125 |
149 |
168 |
167 |
NR |
NR |
NC |
NC |
|
|
Stahl,1984 (2 year follow up) |
108 |
116 |
168 |
167 |
NR |
NR |
NC |
NC |
|
|
Binstock,1988 |
23 |
32 |
156 |
151 |
135 |
148 |
21.0 (16.5) b |
3.0 (16.5) b |
18.0 (9.2 to 26.8) |
|
Midanik,1991 |
74 |
72 |
144 (16) |
144 (17) |
143 (16) |
145 (18) |
1.6 (14.5) |
-0.8 (14.2) |
2.4 (-2.3 to 7.1) |
|
Soghikann,1992 |
200 |
190 |
137 (17) |
140 (18) |
136 (20) |
142 (17) |
1.4 (17.9) |
-1.8 (16.5) |
3.2 (-0.2 to 6.6) |
|
Mulhauser,1993 |
86 |
74 |
162 (14) |
161(13) |
154(16) |
158 (18) |
8.0 (17.0) |
3.0 (18.0) |
5.0 (-0.5 to 10.5) |
|
Friedman,1996 |
133 |
134 |
170 |
167 |
NR |
NR |
11.0 (16.5) b |
10.6 (16.5) b |
0.4 ( -3.6 to 4.4) |
|
Zarnke,1997 |
20 |
11 |
NR |
NR |
NR |
NR |
NC |
NC |
|
|
Bailey,1999 |
31 |
29 |
156 (22) |
155 (22) |
148 (17) |
142 (16) |
8.0 (19.5) a |
13.0 (19.2)a |
-5.0 (-14.8 to 4.8) |
|
Mehos,2000 |
18 |
18 |
158 (16) |
154 (15) |
NR |
NR |
17.1 (14.0) |
7.0 (18.5) |
10.1 (-0.6 to 20.8) |
|
Vetter,2000 |
296 |
326 |
166 (14) |
168 (14) |
145 (16) |
148 (15) |
21.0 (15.1) a |
20.5 (14.2) a |
0.5 ( -1.8 to 2.8) |
|
Artinian,2001 |
6 |
9 |
149 (14) |
142 (17) |
124 (14) |
143 (11) |
24.7 (13.8) a |
-0.9 (13.6) a |
25.6 ( 11.4 to 39.8) |
|
Broege,2001 |
20 |
18 |
150 (22) |
144 (20) |
146 (11) |
144 (19) |
4.0 (16.5) a |
0.0 (19.5) a |
4.0( -7.6 to 15.6) |
|
Rogers,2001 |
60 |
61 |
4.9 (13.0) |
0.1 (13.2) |
4.8 (0.1 to 9.5) |
||||
Where no standard deviation given for baseline and follow up it was not reported. NR – mean not reported aStandard deviation estimated as average of baseline and follow up sd. NC – mean difference either not reported or not calculable. b Standard deviation estimated as average sd.
Appendix D2. Diastolic blood pressure. Mean and standard deviation of baseline, follow up and fall from baseline for intervention and control groups.
|
Author |
Number of subjects |
Baseline dbp |
Follow up dbp |
Fall from baseline |
Intervention effect |
||||
|
I |
C |
I |
C |
I |
C |
I |
C |
(95% CI) |
|
|
Carnaham,1975 |
49 |
48 |
102 |
104 |
91 |
93 |
10.4 (9.3)b |
10.4 (9.3) b |
0.0 ( -3.7 to 3.7) |
|
Haynes,1976 |
20 |
18 |
99 (6) |
98 (6) |
93 (6) |
96 (6) |
5.4 (7.2) |
1.9 (8.5) |
3.5 (-1.5 to 8.5) |
|
Johnson,1978 |
69 |
67 |
103 (7) |
104 (9) |
95 (9) |
96 (11) |
8.5 (9.7) |
8.1 (10.0) |
0.4 ( -2.9 to 3.7) |
|
Earp,1982 |
74 |
41 |
NR |
NR |
NR |
NR |
NC |
NC |
|
|
Earp,1982 |
55 |
34 |
NR |
NR |
NR |
NR |
NC |
NC |
|
|
Pierce,1984 |
55 |
58 |
107 (8) |
104 (9) |
NR |
NR |
19.1 (10.7) |
17.8 (9.1) |
1.3 ( -2.4 to 5.0) |
|
Stah,1984 (1 year) |
125 |
149 |
110 |
109 |
90 |
92 |
20.1 (9.3) b |
17.0 (9.3) b |
3.1 ( 0.9 to 5.3) |
|
Stahl,1984 (2 year) |
108 |
116 |
110 |
109 |
91 |
90 |
19.9 (9.3) b |
19.0 (9.3) b |
0.9 ( -1.5 to 3.3) |
|
Binstock,1988 |
23 |
32 |
93 |
90 |
82 |
89 |
11.0 (9.3) b |
1.0 (9.3) b |
10.0 ( 5.0 to 15.0) |
|
Midanik,1991 |
74 |
72 |
91 (9) |
93 (8) |
92 (10) |
94 (9) |
-1.0 (10.0) |
-0.9 (8.0) |
-0.1 ( -3.0 to 2.8) |
|
Soghikann,1992 |
200 |
190 |
86 (8) |
86 (11) |
86 (10) |
88 (10) |
-0.1 (9.6) |
-1.7 (9.6) |
1.6 ( -0.3 to 3.5) |
|
Mulhauser,1993 |
86 |
74 |
100 (7) |
98 (7) |
95 (9) |
96 (11) |
6.0 (11.0) |
2.0 (10.0) |
4.0 ( 0.7 to 7.3) |
|
Friedman,1996 |
133 |
134 |
86 |
84 |
NR |
NR |
5.4 (9.3) b |
3.3 (9.3) b |
2.1 ( -0.1 to 4.3) |
|
Zarnke,1997 |
20 |
11 |
9.3 |
9.3 |
NR |
NR |
NC |
NC |
|
|
Bailey,1999 |
31 |
29 |
93 (11) |
95 (11) |
89 (11) |
89 (11) |
4.0 (11.1)a |
6.0 (10.8)a |
-2.0 ( -7.5 to 3.5) |
|
Mehos,2000 |
18 |
18 |
91 (11) |
90 (10) |
NR |
NR |
10.5 (7.6) |
3.8 (8.9) |
6.7 ( 1.3 to 12.1) |
|
Vetter,2000 |
296 |
326 |
102 (6) |
102 (6) |
89 (8) |
90 (8) |
13.2 (7.2) a |
11.9 (6.9) a |
1.3 (0.2 to 2.4) |
|
Artinian,2001 |
6 |
9 |
90 (6) |
91 (9) |
76 (11) |
89 (11) |
14.6 (8.6) a |
2.1 (9.7) a |
12.5 ( 3.2 to 21.8) |
|
Broege,2001 |
20 |
18 |
81 (12) |
82 (13) |
80 (8) |
83 (12) |
1.0 (10.0) a |
-1.0 (12.5) a |
2.0 ( -5.2 to 9.2) |
|
Rogers,2001 |
60 |
61 |
NR |
NR |
NR |
NR |
2.0 (8.3) |
-2.1 (9.1) |
4.1 (1.0 to 7.2) |
Where no standard deviation given for baseline and follow up it was not reported. NR – mean not reported aStandard deviation estimated as average of baseline and follow up sd. NC – mean difference either not reported or not calculable. b Standard deviation estimated as average sd.
Appendix D3. Mean arterial pressure . Mean and standard deviation of baseline, follow-up and fall from baseline for intervention and control groups. Only studies reporting this outcome are included
|
Author |
Number of subjects |
Baseline map |
Follow up map |
Fall from baseline |
Intervention effect |
||||
|
I |
C |
I |
C |
I |
C |
I |
C |
(95% CI) |
|
|
Zarnke,1997 |
20 |
11 |
96 (9) |
100 (6) |
NR |
NR |
0.9 (5.8) |
-1.9 (4.6) |
2.9 ( -0.9 to 6.6) |
|
Mehos,2000 |
18 |
18 |
113 (8) |
111 (6) |
NR |
NR |
12.7 (5.9) |
4.9 (9.8) |
7.8 (2.5 to 13.1) |
|
Rogers,2001 |
60 |
61 |
NR |
NR |
NR |
NR |
2.8 (8.9) |
-1.3 (9.3) |
4.1 (0.9 to 7.3) |
NR – mean not reported